ProductLife Group acquires Cilatus and expands its expertise in complex product development

Following the acquisitions of DS InPharmatics (DSI) in 2021 and Zwiers Regulatory Consultancy in 2022, ProductLife Group (PLG), a global provider of regulatory and compliance services to the life sciences industry, further strengthens its capabilities to support product development activities for its clients by acquiring Switzerland-based Cilatus BioPharma Consulting and Ireland-based entity Cilatus Manufacturing Services.

PARIS, May 23, 2023 /PRNewswire/ -- ProductLife Group (PLG), the global, specialist provider of regulatory, vigilance and quality services to the pharmaceutical, biotechnology and medical technology industries, announces the acquisition of the Cilatus Group companies, which provides manufacturing consulting and chemical controls (CMC) and qualified person (QP) services for clients worldwide.

After a successful career in the US (Bayer, IDEC; Biogen, Genentech) and Europe (Bayer, Elan Pharmaceutical, Prothena), Johannes Roebers, PhD, founded Cilatus BioPharma Consulting in 2014. Cilatus specialises in CMC development management, GMP Manufacturing, CDMO /CMO Search and Management, Regulatory Affairs and Quality Assurance of large and small molecules of any dosage form as well as Advanced Therapy Medicines. In 2017, Johannes Roebers launched Cilatus Manufacturing Services, an Irish entity providing licensed QP release and certification services for commercial and investigational medicinal products in accordance with EU GMP requirements.